Company: LRHC
Filing Date: 2025-08-11
Form Type: S-1
Source: 0001213900-25-074405
Chunk: 31

Company: La Rosa Holdings Corp.
Filing Date: 2025-08-11
Form: S-1
Chunk 31
---
 in our sole discretion, also direct the Selling Stockholder
to purchase additional shares of common stock in “accelerated purchases” as set forth in the Facility.

<div align='center'>15</div>

Depending on the prevailing market price of
our common stock, we may not be able to sell shares to the Selling Stockholder for the maximum $150,000,000 over the term of the
Facility. In addition, the Selling Stockholder will not be required to purchase any shares of our common stock if such sale would result in
the Selling Stockholder’s stock exceeding the 4.99% (which the Selling Stockholder, upon notice to the Company, may increase or
decrease but in no event in excess of 9.99%) of the outstanding voting power or number of the common stock. Our inability to access
a portion or the full amount available under the Facility, in the absence of any other financing sources, could have a material
adverse effect on our business.

If obtaining sufficient funding from the Selling Stockholder were
to prove unavailable or prohibitively dilutive, we will need to secure another source of capital in order to satisfy our working capital
needs.

Our management will have broad discretion over the use of the net proceeds, if any, from sales of shares of our common stock to the Selling Stockholder, and you may not agree with how we use the proceeds and the proceeds may not be used effectively.

This Prospectus relates to shares of our common
stock that may be offered and sold from time to time by the Selling Stockholder. We will not receive any proceeds upon the sale of shares by the Selling Stockholder. However,
we may receive gross proceeds of up to $150,000,000 from the sale of shares under the Facility to the Selling Stockholder. The anticipated use of net proceeds
from the sale of our common stock to the Selling Stockholder under the Facility represents our intentions based upon our current plans and business conditions.
Because we have not designated the amount of net proceeds from the sale of shares under the Facility to be used for any particular purpose,
our management will have broad discretion as to the use of the net proceeds from our sale of shares of common stock to the Selling Stockholder. Accordingly,
you will be relying on the judgment of our management with regard to the use of those net proceeds, and you will not have the opportunity,
as part of your investment decision, to assess whether the proceeds are being used appropriately, effectively, or efficiently. It is possible